AAPL   318.35 (+0.03%)
FB   227.22 (+0.78%)
GOOGL   1,428.35 (+0.71%)
AMZN   2,422.41 (+0.89%)
NVDA   344.84 (+1.58%)
CGC   17.86 (-17.77%)
MU   46.72 (+0.54%)
GE   6.65 (-2.06%)
TSLA   811.48 (+0.70%)
AMD   52.51 (+1.49%)
ACB   14.27 (-6.98%)
GILD   75.25 (-0.09%)
DIS   116.37 (-0.33%)
BA   146.48 (-2.23%)
AAPL   318.35 (+0.03%)
FB   227.22 (+0.78%)
GOOGL   1,428.35 (+0.71%)
AMZN   2,422.41 (+0.89%)
NVDA   344.84 (+1.58%)
CGC   17.86 (-17.77%)
MU   46.72 (+0.54%)
GE   6.65 (-2.06%)
TSLA   811.48 (+0.70%)
AMD   52.51 (+1.49%)
ACB   14.27 (-6.98%)
GILD   75.25 (-0.09%)
DIS   116.37 (-0.33%)
BA   146.48 (-2.23%)
AAPL   318.35 (+0.03%)
FB   227.22 (+0.78%)
GOOGL   1,428.35 (+0.71%)
AMZN   2,422.41 (+0.89%)
NVDA   344.84 (+1.58%)
CGC   17.86 (-17.77%)
MU   46.72 (+0.54%)
GE   6.65 (-2.06%)
TSLA   811.48 (+0.70%)
AMD   52.51 (+1.49%)
ACB   14.27 (-6.98%)
GILD   75.25 (-0.09%)
DIS   116.37 (-0.33%)
BA   146.48 (-2.23%)
AAPL   318.35 (+0.03%)
FB   227.22 (+0.78%)
GOOGL   1,428.35 (+0.71%)
AMZN   2,422.41 (+0.89%)
NVDA   344.84 (+1.58%)
CGC   17.86 (-17.77%)
MU   46.72 (+0.54%)
GE   6.65 (-2.06%)
TSLA   811.48 (+0.70%)
AMD   52.51 (+1.49%)
ACB   14.27 (-6.98%)
GILD   75.25 (-0.09%)
DIS   116.37 (-0.33%)
BA   146.48 (-2.23%)
Log in

ASX:M7TMach7 Technologies Stock Price, Forecast & News

A$0.57
-0.01 (-1.71 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$0.54
Now: A$0.58
A$0.58
50-Day Range
A$0.47
MA: A$0.56
A$0.62
52-Week Range
A$0.33
Now: A$0.58
A$0.95
Volume272,627 shs
Average VolumeN/A
Market Capitalization$105.13 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability solutions for healthcare enterprises worldwide. It offers Management Studio that enables healthcare delivery organizations to own, archive, and communicate imaging data from across the enterprise and connect that data with the electronic medical record. The company's Management Studio comprises enterprise imaging platform, vendor neutral archive, communication workflow engine, routing engine, fetching engine, and migration engine products. It also provides Diagnostic Studio that drives specialty workflows. The company's Diagnostic Studio solutions include PACS solution, Universal Worklist, and QC module. In addition, the company offers Clinical Studio, which provides access to view, navigate, review, and share patient medical data over the Web and across the enterprise. Its Clinical Studio solutions consist of clinical portal, clinical viewer, image sharing, and procedure import/export products. Further, the company provides customer training, software installation, and maintenance and support services; and archive migration services. Mach7 Technologies Limited was founded in 2007 and is based in South Burlington, Vermont.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars


Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
CIKN/A
Phone802-861-7745

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$14.91 million
Cash FlowA$0.14 per share
Book ValueA$0.18 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$105.13 million
Next Earnings DateN/A
OptionableNot Optionable

Receive M7T News and Ratings via Email

Sign-up to receive the latest news and ratings for M7T and its competitors with MarketBeat's FREE daily newsletter.

Mach7 Technologies (ASX:M7T) Frequently Asked Questions

How has Mach7 Technologies' stock been impacted by COVID-19 (Coronavirus)?

Mach7 Technologies' stock was trading at A$0.62 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, M7T stock has decreased by 7.3% and is now trading at A$0.58. View which stocks have been most impacted by Coronavirus.

Has Mach7 Technologies been receiving favorable news coverage?

News headlines about M7T stock have been trending extremely negative on Friday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Mach7 Technologies earned a news sentiment score of -4.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutMach7 Technologies.

Who are some of Mach7 Technologies' key competitors?

Who are Mach7 Technologies' key executives?

Mach7 Technologies' management team includes the following people:
  • Mr. Mike Lampron, COO & Interim CEO
  • Mr. Ravi Krishnan, Founder & Chief Strategy Officer
  • Ms. Jennifer Pilcher, Global CFO & Corp. Sec.

What is Mach7 Technologies' stock symbol?

Mach7 Technologies trades on the ASX under the ticker symbol "M7T."

What is Mach7 Technologies' stock price today?

One share of M7T stock can currently be purchased for approximately A$0.58.

How big of a company is Mach7 Technologies?

Mach7 Technologies has a market capitalization of $105.13 million and generates $14.91 million in revenue each year.

What is Mach7 Technologies' official website?

The official website for Mach7 Technologies is www.mach7t.com.

How can I contact Mach7 Technologies?

The company can be reached via phone at 802-861-7745.

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.